FDA Increases Generic Application Fees, Lowers Others, For Fiscal 2021

By Beth Wang / July 31, 2020 at 4:53 PM
FDA will increase its generic drug user fee application and drug master file fees in fiscal 2021 while reducing overall generic program and facility fees across the board, the agency announced Friday (July 31). A former FDA official said the lower program and facility fees are likely due to an uptick in new generic drug firms. Fees for drug master files experience the biggest percentage increase, rising from $57,795 in fiscal 2020 to $69,921 in fiscal 2021 for a 21%...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.